Evidence map›Paper›PMID 30699965›Full record

ArticleMolecules (Basel, Switzerland)2019

4-

Santu K Singha, Ilias Muhammad, Mohamed Ali Ibrahim, Mei Wang, Nicole M Ashpole, Zia Shariat-Madar

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. In Vitro and In Silico Studies of Neolignans fromMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Santu K SinghaDepartment of Biomolecular Sciences, Division of Pharmacology, University of Mississippi, University, MS 38677, USA. sksingha@go.olemiss.edu.
Ilias MuhammadThe National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, MS 38677, USA. milias@olemiss.edu.
Mohamed Ali IbrahimThe National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, MS 38677, USA. mmibrahi@olemiss.edu.ORCID 0000-0003-0257-860X
Mei WangThe National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, MS 38677, USA. meiwang@olemiss.edu.ORCID 0000-0003-3686-4292
Nicole M AshpoleDepartment of Biomolecular Sciences, Division of Pharmacology, University of Mississippi, University, MS 38677, USA. nmashpol@olemiss.edu.
Zia Shariat-MadarDepartment of Biomolecular Sciences, Division of Pharmacology, University of Mississippi, University, MS 38677, USA. madar@olemiss.edu.
University of Mississippi · US

Funding

University of Mississippi OHAUSDA ARS Specific Cooperative Agreement 58-6408-2-00
6 · The paper itself

Abstract

Although 4-

Indexed as

AnimalsBiphenyl CompoundsCardiovascular SystemDisease Models, AnimalEmbryo, NonmammalianHerbal MedicineInflammationLignansMagnoliaMaleOryziasRandom AllocationSignal Transduction4-O-methylhonokiolBiphenyl CompoundsLignanscardiomyogenesisfactor VIIfactor Xherbal medicineinflammationthrombosisvasculogenesis

Identifiers

PMID30699965
PMCPMC6384692
OpenAlexW2911229900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.